Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:30 AM
Ignite Modification Date:
2025-12-25 @ 2:30 AM
NCT ID:
NCT00412334
Eligibility Criteria:
Inclusion Criteria:
* adult patients \>=18 years of age, with CHC genotype 1;
* patients who have failed to respond to previous treatment with PEGASYS plus ribavirin for \>=12 weeks;
* patients who have discontinued PEGASYS/ribavirin \>=4 weeks prior to enrollment;
* compensated liver disease.
Exclusion Criteria:
* other forms of liver disease;
* infection with HIV, HAV, HBV;
* hepatocellular cancer.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00412334
Study Brief:
Protocol Section:
NCT00412334